Alembic Pharmaceuticals Ltd.

APLLTD

Market Cap
₹18,725 Cr.
P/E
30.41

Alembic Pharmaceuticals Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

12 Yes

Positive for this company

2 Neutral

Neutral for this company

3 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
7.83%
3yr Average
13.47%
5yr Average
17.53%
Net Profit Margin
Latest
6.05%
3yr Average
12.38%
5yr Average
13.99%
ROCE
Latest
9.85%
3yr Average
15.72%
5yr Average
19.16%
Debt to Equity
Latest
0.15
3yr Average
0.12
5yr Average
0.26
Market Share
1.40% (as of Jun 23)
Anti - Diabetes - Market Share
2.10% (as of Jun 23)
Anti-Infectives - Market Share
0.14% (as of Nov 21)
Anti-Malarial - Market Share
0.01% (as of Nov 21)
Antineo Plastic - Market Share
0.26% (as of Nov 21)
Blood Related - Market Share
1.80% (as of Jun 23)
Cardiovascular - Market Share
4.20% (as of Jun 23)
Cold & Cough Medication Market Share
locked Source
0.20% (as of Jun 23)
Dermatology - Market Share
locked Source
0.02% (as of Nov 21)
Endocrinology - Market Share
1.20% (as of Jun 23)
Gastro-Intestinal - Market Share
3.10% (as of Jun 23)
Gynecology - Market Share
locked Source
0.10% (as of Nov 21)
Neurological - Market Share
2% (as of Jun 23)
Ophthalmology - Market Share
locked Source
0.83% (as of Nov 21)
Pain - Market Share
1.50% (as of Jun 23)
Pharmaceutical Sector - Market Share
1.85% (as of Nov 21)
Respiratory - Market Share
3.67% (as of Nov 21)
Urology - Market Share
0.80% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up -Domestic Branded Formulation Business

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up -Formulations

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -API

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Formulations

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic

Acute vs Chronic -Formulations

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Number of ANDA's Filed in Latam
      Source
    • Number of ANDA's Approved by Latam
      Source
    • Number of ANDA's Filed in South Africa
      Source
    • Number of ANDA's Approved by South Africa
      Source
    • Number of ANDA's Filed in Australia
      Source
    • Number of ANDA's Approved by Australia
      Source
    • Number of ANDA's Filed in Canada
      Source
    • Number of ANDA's Approved by Canada
      Source
    • Number of ANDA's Filed in Europe
      Source
    • Number of ANDA's Approved in Europe
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Azithral
    Tellzy
    Zeet
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Alembic Pharmaceuticals Ltd.
    View the discussion on ValuePickr
    Corporate Governance Issues At Paushak - Smart Sync Services
    Chemical Sector
    Chemicals Sector - Breakdown and Value Chain - PPFAS
    Chemical Industry - Top Down - Capital Mind
    Battery Chemistry Of EV's - Value Educator
    Indian agrichemical overview - a sectoral perspective - ValuePickr
    Next MegaTrend in Investing : Is Methanol Next "Ethanol"? - Sadhan
    Understanding the Agri-Inputs Industry - PPFAS
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline